SOURCE: Watson Pharmaceuticals

Watson Pharmaceuticals

June 18, 2009 14:28 ET

Watson to Present at Wachovia's 19th Annual Mid-Year Equity Conference

CORONA, CA--(Marketwire - June 18, 2009) - Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, announced today that Paul Bisaro, Watson's president and chief executive officer, will provide an overview and update of the Company's business at Wachovia's 19th Annual Mid-Year Equity Conference on Tuesday, June 23, 2009 at 2:30 p.m. Eastern Daylight Time.

This presentation will be webcast live and can be accessed on Watson Pharmaceuticals' Investor Relations Web site at The webcast can also be accessed at the following URL:

An archived version will be available for 30 days after the live presentation and can be accessed at the same locations.

About Watson Pharmaceuticals, Inc.

Watson Pharmaceuticals, Inc. is a global leader in the development and distribution of pharmaceuticals with a broad portfolio of generic products and a specialized portfolio of brand pharmaceuticals focused on Urology, Women's Health and Nephrology/Medical.

For press releases and other company information, visit Watson Pharmaceuticals' Web site at

Contact Information

    Watson Pharmaceuticals, Inc.
    Patty Eisenhaur
    (951) 493-5611